From: Risk and impact of herpes zoster among COPD patients: a population-based study, 2009–2014
Total Cohort | COPD patients (without ICS) | COPD-ICS patients | |
---|---|---|---|
Age (years) | N (%) | N (%) | N (%) |
50–59 | 1,027,417 | 26,724 | 4041 |
60–69 | 881,947 | 47,698 | 9181 |
70–79 | 699,885 | 59,753 | 12,928 |
≥80 | 414,036 | 47,289 | 11,366 |
Gender | |||
Male | 1, 061,732 (46%) | 96,902(67%) | 16,913 (57%) |
Female | 1, 227,753 (54%) | 47,628 (33%) | 12,795 (43%) |
Nationality | a N = 1,774,750 | a N = 110,366 | a N = 23,425 |
Spanish | 1, 586,043 (89%) | 103,658 (94%) | 22,084 (94%) |
Other | 188,707 (11%) | 6708 (6%) | 1341 (6%) |
Urban status | a N = 2,261,243 | a N = 144,179 | a N = 29,698 |
Urban | 2, 191,837 (97%) | 139,515 (97%) | 28,619 (96%) |
Rural | 69,406 (3%) | 4664 (3%) | 1079 (4%) |
Social Exclusion | a N = 1,739,725 | a N = 109,603 | a N = 23,301 |
Risk | 202,365 (12%) | 9521 (9%) | 1754 (8%) |
No risk | 1, 537,360 (88%) | 100,082 (91%) | 21,547 (92%) |
Comorbidities | |||
Diabetes mellitus | 397,414 (17%)b | 43,553 (30%) b | 9415 (32%) b |
Heart Failure | 103,240 (5%) b | 25,977 (18%) b | 7101 (24%) b |
Total (%) | 2,289,485 | 144,530 (6%) c | 29,708 (1.3%) c |